Zuzana Mlyncekova
Overview
Explore the profile of Zuzana Mlyncekova including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
7
Citations
19
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Macejova A, Kovacova V, Tonhajzerova I, Visnovcova Z, Ferencova N, Mlyncekova Z, et al.
Pharmaceuticals (Basel)
. 2025 Jan;
17(12.
PMID: 39770470
Adolescent treatment resistant depression (TRD) is increasing in recent years. While ketamine showed rapid antidepressant effects in adult TRD studies, research on its effectiveness in adolescents is limited. This study...
2.
Krivosova M, Hutka P, Ondrejka I, Visnovcova Z, Funakova D, Hrtanek I, et al.
Sci Rep
. 2024 Jun;
14(1):14442.
PMID: 38910177
Relationship between depressive disorder and autonomic nervous system has been already discussed. Reduced emotional regulation is supposed to be associated with prefrontal hypofunction and subcortical hyperactivity. The aim of this...
3.
Kukucka T, Ferencova N, Visnovcova Z, Ondrejka I, Hrtanek I, Kovacova V, et al.
Int J Mol Sci
. 2024 Apr;
25(8).
PMID: 38674096
Major depressive disorder is a severe mood disorder associated with a marked decrease in quality of life and social functioning, accompanied by a risk of suicidal behavior. Therefore, seeking out...
4.
Kovacova V, Macejova A, Tonhajzerova I, Visnovcova Z, Ferencova N, Mlyncekova Z, et al.
Pharmaceuticals (Basel)
. 2024 Mar;
17(3).
PMID: 38543144
Ketamine is a potential rapid-onset antidepressant characterized by sympathomimetic effects. However, the question of ketamine's use in treating adolescents' major depressive disorder (MDD) is still discussed. Thus, we aimed to...
5.
Mlyncekova Z, Hutka P, Visnovcova Z, Ferencova N, Kovacova V, Macejova A, et al.
Clocks Sleep
. 2023 Nov;
5(4):627-638.
PMID: 37987393
The relationship between depression and insomnia is bidirectional and both conditions need to be treated adequately, especially in a vulnerable neurodevelopmental stage of adolescence. This study aimed to evaluate the...
6.
Mlyncekova Z, Vysehradsky R, Tonhajzerova I, Hutka P, Krivosova M, Hamrakova A, et al.
Neuro Endocrinol Lett
. 2021 Dec;
42(8):503-507.
PMID: 34969190
This report presents a rare case of adolescent patient treated by novel antidepressant vortioxetine for depressive disorder comorbid to narcolepsy type 1 (NT1) and newly diagnosed REM behavior disorder (RBD)...
7.
Hutka P, Krivosova M, Muchova Z, Tonhajzerova I, Hamrakova A, Mlyncekova Z, et al.
Int J Mol Sci
. 2021 Feb;
22(3).
PMID: 33572767
Sleep problems are frequently associated with the principal diagnostic criteria for many mental disorders. Alterations in the sleep of depressive patients are of high clinical significance because continuous sleep problems...